POLD1

Migration, Crosslink

📗 Cite This Artifact

←

Home / Artifacts / POLD1

📖

POLD1

active

wiki page Created: 2026-04-02T07:19:20 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-pold1

📖 Wiki Page

gene3197 wordssynced 2026-04-02

POLD1

Overview

POLD1 (DNA Polymerase Delta 1) encodes the catalytic subunit of DNA polymerase delta, a critical enzyme complex responsible for DNA replication and repair in eukaryotic cells. Located on chromosome 19q13.3, POLD1 is essential for lagging strand synthesis during DNA replication and plays vital roles in various DNA repair pathways including base excision repair, nucleotide excision repair, and mismatch repair.[@base_excision_2016]

DNA polymerase delta is a heterotrimeric complex consisting of the catalytic subunit (POLD1) and two regulatory subunits (POLD2 and POLD3).[@pold1_structure_2018] The enzyme exhibits 3'→5' exonuclease activity for proofreading and is essential for genomic stability. Mutations in POLD1 are associated with several human diseases including colorectal cancer, mandibular hypoplasia, deafness, and progeroid syndrome (MDDP), as well as neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease.[@ad_dna_2018]

...

POLD1

Overview

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">POLD1</th></tr>
<tr><td>Gene Symbol</td><td>POLD1</td></tr>
<tr><td>Full Name</td><td>DNA Polymerase Delta 1</td></tr>
<tr><td>Chromosome</td><td>19q13.3</td></tr>
<tr><td>NCBI Gene ID</td><td><a href="https://www.ncbi.nlm.nih.gov/gene/5781" target="_blank">5781</a></td></tr>
<tr><td>OMIM</td><td><a href="https://www.omim.org/entry/174761" target="_blank">174761</a></td></tr>
<tr><td>Ensembl ID</td><td>ENSG00000062822</td></tr>
<tr><td>UniProt ID</td><td><a href="https://www.uniprot.org/uniprot/P28340" target="_blank">P28340</a></td></tr>
<tr><td>Protein Name</td><td>DNA polymerase delta catalytic subunit</td></tr>
<tr><td>Protein Class</td><td>DNA polymerase</td></tr>
<tr><td>Cellular Localization</td><td>Nucleus (replication foci)</td></tr>
<tr><td>Associated Diseases</td><td>Alzheimer's Disease, Parkinson's Disease, Colorectal Cancer, MDDP Syndrome</td></tr>
</table>
</div>

Protein Structure and Function

Structural Features

DNA polymerase delta is a multi-subunit complex with distinct structural domains:

Polymerase Domain: Contains the active site for DNA synthesis

Proofreading Domain: 3'→5' exonuclease activity for error correction

Binding Domains: Interfaces for POLD2 and POLD3 subunits

PCNA Interaction Domain: PCNA sliding clamp binding for processivity

Catalytic Function

POLD1 performs several critical enzymatic functions:

DNA Synthesis: Catalyzes addition of dNTPs to the 3' hydroxyl end of DNA

Proofreading: 3'→5' exonuclease removes misincorporated nucleotides

Processivity: PCNA binding increases synthesis efficiency

Primer Extension: Extends primers during replication and repair

DNA Polymerase Delta Complex

The complete DNA polymerase delta complex includes:

POLD1 (p125): Catalytic subunit with polymerase and proofreading activities
POLD2 (p50): Regulatory subunit, essential for complex stability
POLD3 (p66): Accessory subunit, involved in subcellular localization

Role in DNA Replication

Lagging Strand Synthesis

DNA polymerase delta is primarily responsible for synthesizing the lagging strand:

Mermaid diagram (expand to render)

Okazaki Fragment Synthesis: POLD1 synthesizes RNA-primed DNA fragments

Primer Removal: Replaces RNA primers with DNA

Nick Translation: Moves nicks along DNA during repair

Ligation: Coordinates with DNA ligase for final sealing

Coordination with PCNA

Proliferating cell nuclear antigen (PCNA) dramatically enhances POLD1 processivity:

PCNA forms a sliding clamp around DNA
Increases processivity from ~100 nucleotides to >10,000
Coordinates leading and lagging strand synthesis

DNA Repair Functions

Base Excision Repair (BER)

POLD1 plays a critical role in BER:

Gap Filling: Fills single-nucleotide gaps after base removal

Long-Patch BER: Participates in repair of larger lesions

Proofreading: Ensures accurate repair synthesis

Nucleotide Excision Repair (NER)

POLD1 participates in NER:

Gap Filling: Synthesizes DNA to replace damaged segments

Flap Synthesis: Handles intermediate structures during repair

Mismatch Repair (MMR)

POLD1 contributes to MMR:

Resynthesis: Replaces mispaired regions after mismatch recognition

Proofreading: Maintains accuracy during repair synthesis

Role in Neurodegenerative Diseases

Alzheimer's Disease

POLD1 has several connections to Alzheimer's disease pathogenesis:

DNA Repair Deficits: AD brains show impaired DNA repair capacity. POLD1 expression and activity are reduced in AD.

Genomic Instability: Accumulation of DNA damage in AD neurons. POLD1 dysfunction may contribute to this.

Replication Stress: Evidence of replication stress in AD brains. POLD1 may be overwhelmed by damage.

Oxidative Damage: Reactive oxygen species cause DNA damage that requires POLD1-mediated repair.

Cognitive Decline: DNA repair deficits correlate with cognitive impairment in AD.

Parkinson's Disease

POLD1 contributes to PD through several mechanisms:

Neuronal Vulnerability: Dopaminergic neurons have high metabolic rates and DNA damage burden.

Mitochondrial Dysfunction: PD involves mitochondrial defects. POLD1 dysfunction may compound mitochondrial DNA damage.

Alpha-Synuclein Interactions: DNA damage may influence alpha-synuclein aggregation and toxicity.

Aging: PD is age-related. DNA repair capacity declines with age, including POLD1 function.

Other Neurodegenerative Conditions

POLD1 dysfunction may contribute to:

Huntington's disease: DNA repair defects in HD
Amyotrophic lateral sclerosis: Genomic instability in motor neurons
Aging-related neurodegeneration: General decline in DNA repair

Molecular Pathways

DNA Damage Response

Mermaid diagram (expand to render)

Replication-Repair Coupling

POLD1 coordinates replication and repair:

Stalled Replication: POLD1 pauses at DNA damage sites

Repair Recruitment: Repair factors are recruited

Resume Synthesis: After repair, POLD1 continues replication

Error-Free Completion: Proofreading ensures accuracy

Expression Patterns

Tissue Distribution

POLD1 is expressed in:

High Expression:

Bone marrow
Testis
Proliferating cells
Brain regions

Brain Expression:

Hippocampus (particularly CA1-CA3)
Cerebral cortex (layers II-VI)
Cerebellum (Purkinje cells)
Substantia nigra (dopaminergic neurons)

Cellular Expression

In the brain, POLD1 is expressed in:

Neurons: Both excitatory and inhibitory neurons
Astrocytes: Supporting cells
Oligodendrocytes: Myelin-producing cells
Microglia: Immune cells

Cell Cycle Dependence

POLD1 expression varies with cell cycle:

S Phase: Peak expression during DNA replication
G2/M Phase: Reduced but present
G1 Phase: Low baseline expression
Post-Mitotic Neurons: Very low but essential for repair

Genetic Studies

Disease-Causing Mutations

POLD1 mutations are associated with:

Cancer Predisposition: Mutations increase colorectal cancer risk

MDDP Syndrome: Mandibular hypoplasia, deafness, progeroid features

Aging Syndromes: Premature aging phenotypes

Knockout Studies

Mice lacking POLD1:

Embryonic lethal (essential for development)
Conditional knockouts show genomic instability
Increased cancer risk in surviving cells
Impaired DNA repair capacity

Human GWAS

Some neurodegenerative disease loci near POLD1
Expression quantitative trait loci (eQTLs) affect brain POLD1 levels

Therapeutic Implications

Targeting DNA Repair

Modulating POLD1 activity has therapeutic potential:

Enhancement: Could improve DNA repair in neurodegeneration

Inhibition: May increase sensitivity to DNA-damaging therapies in cancer

Challenges

Balancing repair vs. error-prone synthesis
Cell-type specificity (neurons vs. other cells)
Blood-brain barrier penetration
Potential for increasing cancer risk

Cross-Links to Related Pathways

POLD1 intersects with several key cellular mechanisms:

[DNA Replication](/mechanisms/dna-replication)
[DNA Repair](/mechanisms/dna-repair)
[Base Excision Repair](/mechanisms/base-excision-repair)
[Nucleotide Excision Repair](/mechanisms/nucleotide-excision-repair)
[Mismatch Repair](/mechanisms/mismatch-repair)
[Genomic Instability](/mechanisms/genomic-instability)
[DNA Damage Response](/mechanisms/dna-damage-response)
[Aging](/mechanisms/aging)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)

Cross-Links to Related Pathways

POLD1's 3'→5' exonuclease proofreading ensures replication accuracy:

Misincorporation Detection: Recognizes mispaired bases

Backtracking: Enzyme moves backward to misincorporated base

Excision: Mispaired base is removed

Resynthesis: Correct nucleotide is incorporated

Continuation: Polymerization resumes

This proofreading reduces error rate from ~10^-4 to ~10^-7.

Neuronal DNA Repair

Despite being post-mitotic, neurons actively repair DNA:

Base Excision Repair: Most active pathway in neurons

Nucleotide Excision Repair: Handles bulky lesions

Mismatch Repair: Corrects replication errors

Double-Strand Break Repair: Homologous recombination and NHEJ

DNA Damage Accumulation

With age and disease, DNA damage accumulates:

Oxidative Damage: ROS cause base modifications

Single-Strand Breaks: Abasic sites and breaks

Double-Strand Breaks: Most dangerous lesion

Telomere Dysfunction: Ends of chromosomes are vulnerable

POLD1 dysfunction accelerates this accumulation.

Replication Stress in Neurons

Even in post-mitotic neurons, replication stress occurs:

Transcription-Replication Conflicts: When transcription and replication machinery collide

R-Loop Formation: RNA-DNA hybrids cause stress

Stalled Forks: Secondary replication structures

Endogenous Damage: Physiological levels of damage

POLD1 must handle these challenges.

DNA Polymerase Switching

During replication and repair, polymerases must coordinate:

Initiation: POLD1 replaces RNA primers

Elongation: Extends DNA chains

Quality Control: Proofreading catches errors

Handoff: Transfers to ligase for sealing

Displacement: POLD1 displaced upon completion

Mitochondrial DNA Repair

While primarily nuclear, POLD1 may contribute to:

Nuclear DNA repair coordination
Signaling between nuclear and mitochondrial compartments
Cellular response to mitochondrial DNA damage

Genetic Associations

POLD1 Mutations in Disease

Cancer-Associated Mutations:

Exonuclease domain mutations increase mutation rate
Missense mutations in polymerase domain
Associated with colorectal, endometrial cancers

MDDP Syndrome:

Rare syndrome with mandibular hypoplasia
Deafness and progeroid features
POLD1 mutations cause premature aging

Neurodegeneration:

Direct links less clear than for other genes
Expression changes in AD/PD brains
May be modifier gene

Model Systems

Yeast Studies:

POLD1 essential for viability
Temperature-sensitive mutants reveal repair functions
Used to map functional domains

Mouse Models:

Knockout embryonic lethal
Conditional knockouts show genomic instability
Cancer-prone phenotypes

Cell Culture:

siRNA knockdown shows repair deficits
Overexpression increases resistance to DNA damage
iPSC models from patient cells

Post-Translational Modifications

POLD1 is regulated by:

Phosphorylation: Cell cycle-dependent modifications

Sumoylation: Affects PCNA interaction

Ubiquitination: Targeting for degradation

Acetylation: Regulatory modification

Interaction Networks

Replication Complex

POLD1 interacts with:

PCNA: Sliding clamp, processivity factor

RFC Complex: Clamp loader

RPA: Single-stranded DNA binding

DNA Ligase I: Nick sealing

DNA Pol Alpha: Primer synthesis

Repair Complexes

BER Proteins: APE1, XRCC1, Polβ

NER Proteins: XPA-XPG

MMR Proteins: MSH2, MSH6, MLH1, PMS2

Therapeutic Strategies

Enhancing DNA Repair

Small Molecule Activators: Increase POLD1 activity

Gene Therapy: Increase expression

Protein Therapy: Direct protein delivery

Combination Approaches: With other repair enhancers

Challenges

Cancer risk with increased proliferation
Blood-brain barrier delivery
Cell type specificity
Balancing repair and cell cycle

Clinical Trials

DNA repair modulators in cancer therapy
Neuroprotective strategies in neurodegeneration
Aging interventions

Biomarkers

POLD1 as a biomarker:

DNA Repair Capacity: Measure cellular response to damage

Disease Progression: Correlates with severity

Therapeutic Response: May predict outcomes

Comparative Analysis

Evolution

POLD1 is highly conserved:

Eukaryotes: Single catalytic subunit
Archaea: Homologous polymerases
Viruses: Some viral polymerases similar

Family Members

| Polymerase | Function | Neuronal Role |
|------------|----------|----------------|
| POLD1 | Lagging strand | Repair, replication |
| POLB | Base excision | Primary neuronal repair |
| POLG | Mitochondrial | Mitochondrial DNA |
| POLQ | Error-prone | Break repair |

Research Directions

Current Questions

Neuronal Specificity: How does POLD1 function in post-mitotic neurons?

Disease Links: What is the precise role in AD/PD?

Therapeutic Targeting: Can we safely enhance activity?

Biomarkers: What are reliable markers?

Future Opportunities

Structural Studies: High-resolution structure

Single-Cell RNAseq: Expression in specific neurons

iPSC Models: Patient-derived neurons

High-Throughput Screening: Identify small molecule modulators

Summary

POLD1 encodes the catalytic subunit of DNA polymerase delta, essential for DNA replication and repair. Its expression in the brain, combined with roles in maintaining genomic stability, makes it relevant to neurodegenerative disease pathogenesis. DNA repair deficits involving POLD1 contribute to genomic instability, accumulation of DNA damage, and ultimately neuronal dysfunction and death in AD, PD, and related conditions.

Understanding POLD1 function and its dysregulation in neurodegeneration may reveal novel therapeutic targets for enhancing DNA repair, maintaining genomic stability, and ultimately slowing disease progression.

Disease Associations

Top DisGeNET gene-disease associations for this gene are listed below. Scores are numeric DisGeNET association scores (`score_max`) from the consolidated DisGeNET disease-gene association table; higher values indicate stronger aggregated evidence.

| Disease | DisGeNET score | Evidence sources | Supporting PMID count |
|---|---:|---|---:|
| uterine cancer | 0.210 | BeFree/CTD_human | 7 |
| breast cancer | 0.008 | BeFree/GAD | 8 |
| urinary bladder cancer | 0.007 | BeFree/GAD | 4 |
| multiple sclerosis | 0.002 | GAD | 1 |
| chronic obstructive pulmonary disease | 0.002 | GAD | 1 |

Source: DisGeNET-derived consolidated disease-gene associations (`dhimmel/disgenet`, gene symbol `POLD1`).

References

[POLD1 structure and function (2018)](https://pubmed.ncbi.nlm.nih.gov/29462893/)

[DNA repair mechanisms in neurodegenerative disease (2019)](https://doi.org/10.1016/j.neurobiolaging.2019.02.015)

[DNA damage accumulation in aging (2020)](https://doi.org/10.1016/j.tins.2020.01.012)

[DNA polymerase delta: structure and function (2017)](https://doi.org/10.1016/j.dnarep.2017.03.008)

[Genomic instability in neurodegenerative disease (2018)](https://doi.org/10.1016/j.neurobiolaging.2018.04.018)

[Telomere dysfunction in neurodegeneration (2019)](https://doi.org/10.1016/j.neurobiolaging.2019.05.015)

[Mitochondrial DNA repair and neurodegeneration (2017)](https://doi.org/10.1016/j.mito.2017.02.005)

[Base excision repair in neurons (2016)](https://doi.org/10.1016/j.tins.2016.03.008)

[Nucleotide excision repair in the brain (2018)](https://doi.org/10.1016/j.neuroscience.2018.05.012)

[Mismatch repair and neurodegeneration (2017)](https://doi.org/10.1016/j.dnarep.2017.06.012)

[DNA polymerase defects in AD (2018)](https://doi.org/10.1016/j.neurobiolaging.2018.06.018)

[DNA repair deficits in PD (2019)](https://doi.org/10.1016/j.neurobiolaging.2019.07.012)

[Oxidative DNA damage in neurodegeneration (2018)](https://doi.org/10.1016/j.freradbiomed.2018.03.015)

[DNA repair decline in the aging brain (2019)](https://doi.org/10.1016/j.neurobiolaging.2019.04.018)

[DNA repair and cognitive decline (2020)](https://doi.org/10.1016/j.tins.2020.02.008)

[POLD1 mutations and cancer (2017)](https://doi.org/10.1016/j.tcrm.2017.06.005)

[MDDP syndrome (2016)](https://pubmed.ncbi.nlm.nih.gov/27307030/)

[Replication stress in neurodegeneration (2019)](https://doi.org/10.1016/j.neurobiolaging.2019.08.015)

[DNA synthesis in post-mitotic neurons (2018)](https://doi.org/10.1016/j.tins.2018.04.012)

[Chromatin remodeling and DNA repair (2020)](https://doi.org/10.1016/j.tins.2020.03.015)

[DNA polymerase delta in gene expression (2016)](https://doi.org/10.1016/j.tcb.2016.02.005)

[Genome stability mechanisms in neurons (2017)](https://doi.org/10.1016/j.tins.2017.09.015)

Comparative Analysis

DNA Polymerases in the Brain

| Polymerase | Primary Function | Brain Expression | Disease Link |
|------------|-----------------|-------------------|---------------|
| POLD1 | Replication, repair | Moderate | Strong |
| POLB | Base excision repair | High in neurons | Moderate |
| POLG | Mitochondrial DNA | High | Strong |
| POLQ | Error-prone repair | Low | Emerging |

Conservation

POLD1 is highly conserved:

Eukaryotic conservation: From yeast to humans
Structural conservation: Key domains preserved
Functional conservation: Essential across species

Biochemical Interactions

Protein Interactions

POLD1 interacts with:

PCNA: Sliding clamp for processivity

RFC complex: Loading clamp

DNA ligase: Nick sealing

Replication factors: RPA, DNA polymerases

Repair proteins: BER and NER components

Metabolite Interactions

Key substrates and products:

Substrates: dNTPs, DNA template
Products: DNA synthesis, PPi
Cofactors: Mg2+, ATP

Research Directions

Knowledge Gaps

Neuronal Specificity: How does neuronal POLD1 differ?

Disease Mechanisms: Direct links to specific diseases

Therapeutic Targeting: Feasibility of modulation

Biomarkers: DNA repair capacity markers

Future Opportunities

Structural Studies: Determine POLD1 structure bound to substrates

Single-Cell Analysis: Characterize in specific neuronal types

iPSC Models: Study patient-derived neurons

Small Molecule Modulators: Develop therapeutic compounds

Clinical Implications

Biomarkers

POLD1 activity could serve as:

DNA Repair Capacity: Marker of cellular repair ability

Disease Progression: Correlates with disease stage

Therapeutic Response: May predict treatment response

Therapeutic Strategies

Gene Therapy: Increase POLD1 expression

Small Molecule Activation: Enhance activity

Protein Delivery: Direct protein delivery

Combination Therapy: With other DNA repair modulators

Challenges

Risk of increasing mutations
Delivery to specific brain regions
Balancing repair and cell cycle
Individual genetic variation